Fig. 1 · Structure
Documents & Downloads
Envudeucitinibum
TYK2 Inhibitor
Envudeucitinibum is a selective, allosteric inhibitor of TYK2, specifically targeting the JH2 domain. This compound effectively diminishes the signaling pathways responsible for the production of pro-inflammatory cytokines such as IL-12, IL-23, IL-17, and type I interferons. Envudeucitinibum is valuable in research focused on plaque psoriasis, systemic lupus erythematosus (SLE), and other immune-mediated disorders.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 2417135-66-9 |
| Applications | TYK2 Inhibitor |
| Formula | C22H18D6N6O3 |
| Molecular Weight | 426.50 |
| Synonyms | Envudeucitinib; ESK-001 |
| SMILES | COC1=C(C2=NN(C([2H])([2H])[2H])C=N2)C=CC=C1NC3=CC(NC(C4CC4)=O)=NC=C3C(CC([2H])([2H])[2H])=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.